![Richard Fair](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Richard Fair
Chief Executive Officer at
ENLIVEN THERAPEUTICS, INC.
Profile
Mr. Richard A. Fair is a Chief Executive Officer & Director at Enliven Therapeutics, Inc. /US/, a President, Chief Executive Officer & Director at Enliven Therapeutics, Inc. and a President & Director at Bellicum Pharmaceuticals, Inc. He is on the Board of Directors at Enliven Therapeutics, Inc. /US/, Enliven Therapeutics, Inc. and Bellicum Pharmaceuticals, Inc. Mr. Fair was previously employed as an Independent Director by Clovis Oncology, Inc., a SVP & Head-Therapeutic Oncology Global Product by Genentech, Inc., and a Franchise Head-Hematology by Roche Pharma (Schweiz) AG.
He received his undergraduate degree from the University of Michigan and an MBA from Columbia Business School.
Richard Fair active positions
| Companies | Position | Start |
|---|---|---|
| BELLICUM PHARMACEUTICALS, INC. | President | 2017-01-30 |
| ENLIVEN THERAPEUTICS, INC. | Chief Executive Officer | 2025-12-10 |
Enliven Therapeutics, Inc. /US/
 Enliven Therapeutics, Inc. /US/ BiotechnologyHealth Technology Engages in discovery and development of small molecule treatments for cancer | Chief Executive Officer | 2025-12-10 |
Former positions of Richard Fair
| Companies | Position | End |
|---|---|---|
| CLOVIS ONCOLOGY, INC. | Director/Board Member | 2023-07-09 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Corporate Officer/Principal | 2016-12-31 |
Roche Pharma (Schweiz) AG
 Roche Pharma (Schweiz) AG Medical DistributorsDistribution Services Wholesales pharmaceutical products | Corporate Officer/Principal | - |
Training of Richard Fair
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
96
1st degree connections
8
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 8 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Bellicum Pharmaceuticals, Inc.
 Bellicum Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops novel cellular immunotherapies for various forms of cancer | Health Technology |
University of Michigan
 University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Clovis Oncology, Inc.
 Clovis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Operates as an biopharmaceutical company that acquires, develops and commercializes innovative anti cancer agents | Health Technology |
Roche Pharma (Schweiz) AG
Roche Pharma (Schweiz) AG Medical DistributorsDistribution Services Wholesales pharmaceutical products | Distribution Services |
Columbia Business School
 Columbia Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Enliven Therapeutics, Inc. /US/
Enliven Therapeutics, Inc. /US/ BiotechnologyHealth Technology Engages in discovery and development of small molecule treatments for cancer | Health Technology |
Enliven Therapeutics, Inc.
 Enliven Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage precision oncology company that develops molecule therapies | Health Technology |
- Stock Market
- Insiders
- Richard Fair
